These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16022568)

  • 1. CCR1 antagonists in clinical development.
    Pease JE; Horuk R
    Expert Opin Investig Drugs; 2005 Jul; 14(7):785-96. PubMed ID: 16022568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR1 antagonists for the treatment of autoimmune diseases.
    Gladue RP; Zwillich SH; Clucas AT; Brown MF
    Curr Opin Investig Drugs; 2004 May; 5(5):499-504. PubMed ID: 15202722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical potential of chemokine receptor antagonists.
    Ribeiro S; Horuk R
    Pharmacol Ther; 2005 Jul; 107(1):44-58. PubMed ID: 15894378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.
    Gladue RP; Tylaska LA; Brissette WH; Lira PD; Kath JC; Poss CS; Brown MF; Paradis TJ; Conklyn MJ; Ogborne KT; McGlynn MA; Lillie BM; DiRico AP; Mairs EN; McElroy EB; Martin WH; Stock IA; Shepard RM; Showell HJ; Neote K
    J Biol Chem; 2003 Oct; 278(42):40473-80. PubMed ID: 12909630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR1 chemokine receptor antagonist.
    Saeki T; Naya A
    Curr Pharm Des; 2003; 9(15):1201-8. PubMed ID: 12769747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of chemokines and chemokine receptors during human renal transplant rejection.
    Segerer S; Cui Y; Eitner F; Goodpaster T; Hudkins KL; Mack M; Cartron JP; Colin Y; Schlondorff D; Alpers CE
    Am J Kidney Dis; 2001 Mar; 37(3):518-31. PubMed ID: 11228176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.
    Szekanecz Z; Koch AE; Tak PP
    Neth J Med; 2011 Sep; 69(9):356-66. PubMed ID: 21978977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.
    Tian Y; New DC; Yung LY; Allen RA; Slocombe PM; Twomey BM; Lee MMK; Wong YH
    Eur J Immunol; 2004 Mar; 34(3):785-795. PubMed ID: 14991608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.
    Matsui M; Weaver J; Proudfoot AE; Wujek JR; Wei T; Richer E; Trapp BD; Rao A; Ransohoff RM
    J Neuroimmunol; 2002 Jul; 128(1-2):16-22. PubMed ID: 12098506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BX-471 Berlex.
    Elices MJ
    Curr Opin Investig Drugs; 2002 Jun; 3(6):865-9. PubMed ID: 12137405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming hurdles in developing successful drugs targeting chemokine receptors.
    Schall TJ; Proudfoot AE
    Nat Rev Immunol; 2011 May; 11(5):355-63. PubMed ID: 21494268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338.
    Carter PH; Hynes J
    Expert Opin Ther Pat; 2010 Nov; 20(11):1609-18. PubMed ID: 20858032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines and chemokine receptors in renal transplantation--from bench to bedside.
    Fischereder M
    Acta Physiol Hung; 2007 Mar; 94(1-2):67-81. PubMed ID: 17444276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel non-peptide CCR1 receptor antagonists.
    Ng HP; May K; Bauman JG; Ghannam A; Islam I; Liang M; Horuk R; Hesselgesser J; Snider RM; Perez HD; Morrissey MM
    J Med Chem; 1999 Nov; 42(22):4680-94. PubMed ID: 10579830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.
    Haringman JJ; Smeets TJ; Reinders-Blankert P; Tak PP
    Ann Rheum Dis; 2006 Mar; 65(3):294-300. PubMed ID: 16107514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.
    Gao W; Topham PS; King JA; Smiley ST; Csizmadia V; Lu B; Gerard CJ; Hancock WW
    J Clin Invest; 2000 Jan; 105(1):35-44. PubMed ID: 10619859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Chemokine receptors as therapeutic targets: Why aren't there more drugs?".
    Solari R; Pease JE; Begg M
    Eur J Pharmacol; 2015 Jan; 746():363-7. PubMed ID: 25016087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of chemokine signaling in patients with multiple sclerosis.
    Zipp F; Hartung HP; Hillert J; Schimrigk S; Trebst C; Stangel M; Infante-Duarte C; Jakobs P; Wolf C; Sandbrink R; Pohl C; Filippi M;
    Neurology; 2006 Nov; 67(10):1880-3. PubMed ID: 17130431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemokine--possible new options for the treatment of multiple sclerosis].
    Trebst C; Ransohoff RM; Windhagen A; Stangel M
    Nervenarzt; 2003 Oct; 74(10):850-7. PubMed ID: 14551688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.